The new technology-as-a-service (TaaS) bundle combines the ActivSight delivery system with the ActivInsights software suite
Activ Surgical has launched ActivInsights software suite, its augmented reality (AR)-based bundle that offers real-time tissue assessment as visual overlays.
The company said that its new ActivInsights software suite, together with its interoperable imaging module is the first commercially available product in the ActivEdge platform.
ActivEdge has been designed to process large amounts of data gathered intra-operatively to provide surgeons with real-time guidance in the operating room.
Activ Surgical founder and chief science and medical officer Peter Kim said: “I founded Activ Surgical in 2017 with the goal of democratizing surgical care by extending insights from leading surgeons to all surgical systems, regardless of location.
“Bringing our ActivInsights offerings to market is a significant step in realizing this goal as it will provide meaningful visual data that was previously unavailable in the OR to surgeons all across the globe.”
Detecting blood flow is critical in most surgical procedures, where surgeons depend on their skill and training or use expensive surgical visualisation towers to determine the blood flow.
The company is planning to offer Perfusion View Insight as the first offering from the ActivInsights software suite to help surgeons visualise blood flow and perfusion in real-time, eliminating the use of traditional dyes.
Perfusion View Insight will be based on multi-spectral imaging, and its visual overlays are derived from proprietary sensing technologies.
The ActivInsights AR software suite is expected to be supported by the industry’s largest annotated data set planned to be developed by Activ Surgical in the coming 12 months.
Offered through a technology-as-a-service (TaaS) pricing model, the new software suite includes intraoperative hardware, dubbed ActivSight for enhanced surgical visualisation.
Activ Surgical has secured the Food and Drug Administration (FDA) 510(k) clearance for its ActivSight product in April this year.
The company is planning to globally commercialise its ActivInsights augmented reality software suite to healthcare systems in 2022.